Silvia Vega-Rubin-de-Celis

Years Active: 2021-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Jetsy Montero-Vergara, Kira Plachetta, Lisa Kinch, Stephan Bernhardt, Kriti Kashyap, Beth Levine, Lipi Thukral, Martina Vetter, Christoph Thomssen, Stefan Wiemann, Samuel Peña-Llopis, Verena Jendrossek, Silvia Vega-Rubin-de-Celis
GRB2 is a BECN1 interacting protein that regulates autophagy. Cell death & disease 15 (1) (2024)
Jetsy Montero-Vergara, Kira Plachetta, Lisa Kinch, Stephan Bernhardt, Kriti Kashyap, Beth Levine, Lipi Thukral, Martina Vetter, Christoph Thomssen, Stefan Wiemann, Samuel Peña-Llopis, Verena Jendrossek, Silvia Vega-Rubin-de-Celis
GRB2 is a BECN1 interacting protein that regulates autophagy. Cell death & disease 15 (1) (2024)
Jetsy Montero-Vergara, Kira Plachetta, Lisa Kinch, Stephan Bernhardt, Kriti Kashyap, Beth Levine, Lipi Thukral, Martina Vetter, Christoph Thomssen, Stefan Wiemann, Samuel Peña-Llopis, Verena Jendrossek, Silvia Vega-Rubin-de-Celis
GRB2 is a BECN1 interacting protein that regulates autophagy. Cell death & disease 15 (1) (2024)
Devina Mitra, Silvia Vega-Rubin-de-Celis, Nadine Royla, Stephan Bernhardt, Heike Wilhelm, Nooraldeen Tarade, Gernot Poschet, Michael Buettner, Ilona Binenbaum, Simone Borgoni, Martina Vetter, Eva Johanna Kantelhardt, Christoph Thomssen, Aristotelis Chatziioannou, Rüdiger Hell, Stefan Kempa, Karin Müller-Decker, Stefan Wiemann
Abrogating GPT2 in triple-negative breast cancer inhibits tumor growth and promotes autophagy. International journal of cancer 148 (8) (2021)

Silvia Vega-Rubin-de-Celis.css-eqlu8i{font-size:small;padding-left:4px;}